Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Clinical insights
Key research benefits
An FDA-approved (2010, Egrifta), stabilized GHRH analog — the growth-hormone peptide with the strongest human clinical trial base.
- ~15% visceral fat reduction in a 412-patient, 26-week randomized trial; a 2026 meta-analysis of 5 RCTs confirmed the effect plus a 1.42 kg lean mass increase.
- ~37% reduction in liver fat, with fibrosis progression cut from 37% to 10% in a dedicated fatty-liver trial.
- FDA-approved therapeutic with the deepest published safety record of any GH-secretagogue in this guide.
Research backing
Falutz et al., NEJM 2007 & JAIDS 2010 (pivotal 412-patient trial); Stanley et al., Lancet HIV 2019 (NAFLD trial); Badran et al., 2026 meta-analysis (5 RCTs). All major trials were in HIV-associated lipodystrophy populations.
Research Grade Formula
Tesamorelin
Muscle Growth & Hormone Optimization
Tesamorelin · 10mg
$145
Express Shipping $20 — Australia only
- Third-party tested
- Non-GMO
- GMP certified
How to use
Follow research handling and reconstitution guidance for this compound. Always use appropriate lab technique and sterile materials.
Research Dosage ProtocolWhat's inside
The vial contains Tesamorelin, a GHRH-analogue research peptide used in endocrine and body-composition laboratory models. Packaged as a lyophilized powder for controlled reconstitution.
Technical overview
- Contents: Tesamorelin research peptide, 10 mg class vial
- Class: Growth hormone–releasing hormone analogue
- Purity: ≥99% with batch Certificate of Analysis
- Appearance: White lyophilized powder
- Reconstitution: Bacteriostatic water; maintain sterile technique
- Post-mix storage: Refrigerate and use within standard research windows
Reconstitute with bacteriostatic water at room temperature. For laboratory research and educational use only — not for human consumption.
Customer reviews
4.9
Based on 312 reviews
